BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Report Library

All Reports
Datamonitor Healthcare I&I: Sjogren's Syndrome Market Spotlight

March 04, 2020

Sjögren’s syndrome is an autoimmune chronic inflammatory disorder of unknown origin that particularly affects the salivary and tear glands. Dry eyes and dry mouth are the most common symptoms of the disease, while other symptoms may include dryness in the skin, throat, and nose. The disease can also affect other organs and parts of the body, such as the nerves, lungs, blood vessels, joints, digestive organs, and kidneys. Furthermore, approximately 5% of patients with Sjögren’s syndrome may develop B-cell non-Hodgkin’s lymphoma. Sjögren’s syndrome can occur either alone as a primary disease, or as a secondary disease associated with other autoimmune disorders such as scleroderma, lupus, or rheumatoid arthritis.

This Datamonitor Healthcare report contains a Market Spotlight module.
Indications Covered: Sjogren's Syndrome
Back to the top Back to the top